What does DR. ROGOJAN CORNELIA do?

DR. ROGOJAN CORNELIA is a specialist medical practice in Heusden-Zolder. Private Limited, started on 12 May 2016, 1 establishment.

What is the address of DR. ROGOJAN CORNELIA?

The registered office of DR. ROGOJAN CORNELIA is located at Reeënlaan 84, 3550 Heusden-Zolder.

Is DR. ROGOJAN CORNELIA still active?

Yes. According to the CBE (18 September 2026) DR. ROGOJAN CORNELIA is active, legal situation “Normale toestand”, started on 12 May 2016.

Is DR. ROGOJAN CORNELIA registered on Peppol?

No, DR. ROGOJAN CORNELIA is currently not registered on the Peppol network.

What is the enterprise number of DR. ROGOJAN CORNELIA?

The enterprise number of DR. ROGOJAN CORNELIA is BE0653955390.

When was DR. ROGOJAN CORNELIA founded?

DR. ROGOJAN CORNELIA was founded on 12 May 2016.

Who are the directors of DR. ROGOJAN CORNELIA?

According to the 2025 annual accounts, the directors of DR. ROGOJAN CORNELIA are: Cornelia Rogojan.

Is DR. ROGOJAN CORNELIA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 May 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. ROGOJAN CORNELIA make in 2025?

DR. ROGOJAN CORNELIA posted a profit after taxes of € 165,821 in financial year 2025.

What is the revenue of DR. ROGOJAN CORNELIA?

As a small company, DR. ROGOJAN CORNELIA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 232,539.

DR. ROGOJAN CORNELIA (Private Limited) - Heusden-Zolder

Dossier DR. ROGOJAN CORNELIA, printed on 18 September 2026 from databakkes.be/en/0653955390/dr-rogojan-cornelia. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR. ROGOJAN CORNELIA from Heusden-Zolder, company number BE0653955390, closed financial year 2025 with a result of € 165,821 after tax. For that financial year DR. ROGOJAN CORNELIA recorded a gross margin of € 232,539 and equity of € 2,053. Compared with financial year 2024, the result moved from € 92,347 to € 165,821. Profitable, and profit is growing. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Shrank hard

€ 2,053

▼ 99% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 165,821

▲ 80% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 409,133

▲ 52% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 439,343 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 39,407

▼ 23% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 37,990

▼ 24% vs 2024

€ 12,868 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 4,442

▼ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,206

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 57,813 Gross margin 2022: € 57,813 First fiscal year in the series	€ 75,631 Gross margin 2023: € 75,631 ▲ 31% vs 2022 (€ 57,813) Favourable step	€ 135,160 Gross margin 2024: € 135,160 ▲ 79% vs 2023 (€ 75,631) Favourable step	€ 232,539 Gross margin 2025: € 232,539 ▲ 72% vs 2024 (€ 135,160) Favourable step	▲ 72%
Profit after taxes	€ 41,989 Profit after taxes 2022: € 41,989 First fiscal year in the series	€ 56,230 Profit after taxes 2023: € 56,230 ▲ 34% vs 2022 (€ 41,989) Favourable step	€ 92,347 Profit after taxes 2024: € 92,347 ▲ 64% vs 2023 (€ 56,230) Favourable step	€ 165,821 Profit after taxes 2025: € 165,821 ▲ 80% vs 2024 (€ 92,347) Favourable step	▲ 80%
Equity	€ 145,597 Equity 2022: € 145,597 First fiscal year in the series	€ 201,827 Equity 2023: € 201,827 ▲ 39% vs 2022 (€ 145,597) Favourable step	€ 275,574 Equity 2024: € 275,574 ▲ 37% vs 2023 (€ 201,827) Favourable step	€ 2,053 Equity 2025: € 2,053 ▼ 99% vs 2024 (€ 275,574) Unfavourable step	▼ 99%
Total debts	€ 24,561 Total debts 2022: € 24,561 First fiscal year in the series	€ 68,546 Total debts 2023: € 68,546 ▲ 179% vs 2022 (€ 24,561) Unfavourable step	€ 55,933 Total debts 2024: € 55,933 ▼ 18% vs 2023 (€ 68,546) Favourable step	€ 452,228 Total debts 2025: € 452,228 ▲ € 396,294 vs 2024 (€ 55,933) Unfavourable step	▲ € 396,294
Cash	€ 167,809 Cash 2022: € 167,809 First fiscal year in the series	€ 200,539 Cash 2023: € 200,539 ▲ 20% vs 2022 (€ 167,809) Favourable step	€ 269,806 Cash 2024: € 269,806 ▲ 35% vs 2023 (€ 200,539) Favourable step	€ 409,133 Cash 2025: € 409,133 ▲ 52% vs 2024 (€ 269,806) Favourable step	▲ 52%
Retained profit	€ 126,997 Retained profit 2022: € 126,997 First fiscal year in the series	€ 183,227 Retained profit 2023: € 183,227 ▲ 44% vs 2022 (€ 126,997) Favourable step	€ 275,574 Retained profit 2024: € 275,574 ▲ 50% vs 2023 (€ 183,227) Favourable step	€ 2,053 Retained profit 2025: € 2,053 ▼ 99% vs 2024 (€ 275,574) Unfavourable step	▼ 99%
Dividend	€ 1,600 Dividend 2022: € 1,600 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 1,600) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 439,343 Dividend 2025: € 439,343 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 62,080 Bank debt 2023: € 62,080 Unchanged (€ 0) Unfavourable step	€ 50,301 Bank debt 2024: € 50,301 ▼ 19% vs 2023 (€ 62,080) Favourable step	€ 37,990 Bank debt 2025: € 37,990 ▼ 24% vs 2024 (€ 50,301) Favourable step	▼ 24%
Balance sheet total	€ 170,158 Balance sheet total 2022: € 170,158 First fiscal year in the series	€ 270,373 Balance sheet total 2023: € 270,373 ▲ 59% vs 2022 (€ 170,158) Unchanged	€ 331,507 Balance sheet total 2024: € 331,507 ▲ 23% vs 2023 (€ 270,373) Unchanged	€ 454,280 Balance sheet total 2025: € 454,280 ▲ 37% vs 2024 (€ 331,507) Unchanged	▲ 37%

Key figures of DR. ROGOJAN CORNELIA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. ROGOJAN CORNELIA?

What happened at DR. ROGOJAN CORNELIA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 165,821 (▲ 80% vs 2024). Source: NBB ↗
May 12, 2016 New establishment in Heusden-Zolder. KBO
May 12, 2016 Start of the company according to the CBE. KBO
2016 Cornelia Rogojan became a director. NBB

In short

From € 41,989 profit in 2022 to € 165,821 profit in 2025.

Paid € 108,200 in corporate taxes since 2022.

Best year ever: 2025, with € 165,821 profit.

Paid out € 440,943 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. ROGOJAN CORNELIA? We notify you, reason included.

Follow DR. ROGOJAN CORNELIA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Cornelia Rogojan

DR. ROGOJAN CORNELIA

Behind DR. ROGOJAN CORNELIA is Cornelia Rogojan.

See the full network in the app

Directors

According to the 2025 annual accounts

Cornelia Rogojan

Director

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Reeënlaan 84

3550 Heusden-Zolder

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0653.955.390
VAT number: BE 0653.955.390
Registered office: Reeënlaan 84, 3550 Heusden-Zolder
Names & denominations: DR. ROGOJAN CORNELIA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 12 May 2016
Peppol: Not registered
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗